应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
VRTX 福泰制药
交易中 08-15 14:01:55 EDT
394.13
+3.83
+0.98%
最高
395.76
最低
388.71
成交量
79.63万
今开
391.49
昨收
390.30
日振幅
1.81%
总市值
1,011亿
流通市值
1,007亿
总股本
2.56亿
成交额
3.13亿
换手率
0.31%
流通股本
2.56亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating
MT Newswires Live · 08-13 18:22
Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating
福泰制药8月11日成交额为10.48亿美元
市场透视 · 08-12
福泰制药8月11日成交额为10.48亿美元
福泰制药8月8日成交额为13.56亿美元
市场透视 · 08-09
福泰制药8月8日成交额为13.56亿美元
Vertex, Inc.盘中异动 早盘大幅下挫5.02%
市场透视 · 08-08
Vertex, Inc.盘中异动 早盘大幅下挫5.02%
福泰制药8月7日成交额为15.13亿美元
市场透视 · 08-08
福泰制药8月7日成交额为15.13亿美元
Vertex, Inc.盘中异动 早盘股价大涨5.50%
市场透视 · 08-07
Vertex, Inc.盘中异动 早盘股价大涨5.50%
福泰制药8月6日成交额为18.16亿美元
市场透视 · 08-07
福泰制药8月6日成交额为18.16亿美元
美股财报 | Vertex发布Q2财报 前半年累计净利润同比增长29.57%
同花顺iNews · 08-07
美股财报 | Vertex发布Q2财报 前半年累计净利润同比增长29.57%
Vertex Pharmaceuticals Shares Rise After Upgrade From Wells Fargo
MT Newswires Live · 08-07
Vertex Pharmaceuticals Shares Rise After Upgrade From Wells Fargo
Vertex, Inc.盘中异动 急速下挫18.39%
市场透视 · 08-06
Vertex, Inc.盘中异动 急速下挫18.39%
打不过安慰剂，福泰制药一款镇痛药折戟
动脉网 · 08-06
打不过安慰剂，福泰制药一款镇痛药折戟
Vertex Q2 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $184.559M Miss $184.595M Estimate
Benzinga · 08-06
Vertex Q2 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $184.559M Miss $184.595M Estimate
福泰制药8月5日成交额为41.82亿美元
市场透视 · 08-06
福泰制药8月5日成交额为41.82亿美元
美股成交额TOP 20｜Palantir涨近8%，Coinbase跌超6%；福泰制药绩后跌20%，HIMS跌超12%
环球市场播报 · 08-06
美股成交额TOP 20｜Palantir涨近8%，Coinbase跌超6%；福泰制药绩后跌20%，HIMS跌超12%
Palantir营收首破10亿美元，特斯拉遭股东起诉
DoNews · 08-06
Palantir营收首破10亿美元，特斯拉遭股东起诉
标普500指数初步收跌0.4%科技、电信板块至多跌0.9%。纳斯达克100指数跌0.6%成分股VRTX跌20%格芯跌9.
智通财经 · 08-06
标普500指数初步收跌0.4%科技、电信板块至多跌0.9%。纳斯达克100指数跌0.6%成分股VRTX跌20%格芯跌9.
These Analysts Cut Their Forecasts On Vertex Pharmaceuticals After Q2 Results
Benzinga · 08-06
These Analysts Cut Their Forecasts On Vertex Pharmaceuticals After Q2 Results
异动解读 | 福泰制药股价盘中大跌15.32%，止痛药VX-993临床试验失败
异动解读 · 08-05
异动解读 | 福泰制药股价盘中大跌15.32%，止痛药VX-993临床试验失败
异动解读 | 福泰制药新型止痛药临床试验失败，盘前股价大跌14.64%
异动解读 · 08-05
异动解读 | 福泰制药新型止痛药临床试验失败，盘前股价大跌14.64%
Bernstein Adjusts PT on Vertex Pharmaceuticals to $471 From $462, Maintains Market Perform Rating
MT Newswires Live · 08-05
Bernstein Adjusts PT on Vertex Pharmaceuticals to $471 From $462, Maintains Market Perform Rating
加载更多
公司概况
公司名称：
福泰制药
所属市场：
NASDAQ
上市日期：
--
主营业务：
Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品：KALYDECO和INCIVEK。
发行价格：
--
{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":394.13,"timestamp":1755280914798,"preClose":390.3,"halted":0,"volume":796255,"delay":0,"floatShares":255587097,"shares":256390651,"eps":14.070148,"marketStatus":"交易中","change":3.83,"latestTime":"08-15 14:01:55 EDT","open":391.49,"high":395.76,"low":388.71,"amount":312647089.2097,"amplitude":0.018063,"askPrice":394.03,"askSize":2,"bidPrice":393.62,"bidSize":2,"shortable":3,"etf":0,"ttmEps":14.070148,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1755288000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":390.3,"preHourTrading":{"tag":"盘前","latestPrice":388.04,"preClose":390.3,"latestTime":"09:29 EDT","volume":6937,"amount":2710093.32888,"timestamp":1755264599334},"postHourTrading":{"tag":"盘后","latestPrice":390.3,"preClose":390.3,"latestTime":"19:58 EDT","volume":80369,"amount":31369066.98,"timestamp":1755215930199},"volumeRatio":0.470405,"impliedVol":0.268,"impliedVolPercentile":0.128},"requestUrl":"/m/hq/s/VRTX","defaultTab":"news","newsList":[{"id":"2559606365","title":"Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2559606365","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559606365?lang=zh_cn&edition=full","pubTime":"2025-08-13 18:22","pubTimestamp":1755080560,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has an average rating of overweight and mean price target of $491, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"大和证券将Vertex Pharmaceuticals目标价从530美元调整至430美元，维持买入评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2558610602","title":"福泰制药8月11日成交额为10.48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558610602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558610602?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:11","pubTimestamp":1754986315,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，福泰制药成交额为10.48亿美元，成交额较昨日减少22.73%，当日成交量为279.27万股。福泰制药于2025年8月11日涨2.16%，报374.46美元，该股过去5个交易日跌20.71%，年初至今跌7.01%，过去60日跌11.09%。其主要药物是Kalydeco、Orkambi、Symdeko和Trikafta/Kaftrio，以及用于治疗囊性纤维化的Alyftrek。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。福泰也在研究细胞疗法，为1型糖尿病提供潜在的功能性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165148a6e14de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU1674673691.USD","BK4567","LU2417539215.USD","VRTX","IE0009355771.USD","LU0058720904.USD","LU0061475181.USD","LU0320765992.SGD","LU0432979614.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU1093756325.SGD","SG9999013999.USD","SG9999001176.USD","LU1035775433.USD","IE00B19Z9P08.USD","LU2462157665.USD","LU1674673428.USD","LU0109394709.USD","LU1069344957.HKD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","IE00B894F039.SGD","SGXZ57979304.SGD","IE0002141913.USD","IE00B2B36J28.USD","SG9999001176.SGD","BK4588","LU1430594728.SGD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU0256863811.USD","LU1093756168.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","IE00B19Z9Z06.USD","BK4585","LU0823416689.USD","LU0289739699.SGD","LU2362541513.USD","LU2362540622.SGD","LU1585245621.USD","LU2236285917.USD","LU2456880835.USD","BK4139","BK4532","LU1778281490.HKD","LU2237438978.USD"],"gpt_icon":0},{"id":"2558509452","title":"福泰制药8月8日成交额为13.56亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558509452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558509452?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:09","pubTimestamp":1754726977,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，福泰制药成交额为13.56亿美元，成交额较昨日减少10.36%，当日成交量为368.03万股。福泰制药于2025年8月8日跌2.42%，报366.54美元，该股过去5个交易日跌20.68%，年初至今跌8.98%，过去60日跌15.15%。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。福泰也在研究细胞疗法，为1型糖尿病提供潜在的功能性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809160946a47e8a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","IE00B19Z3581.USD","LU1674673428.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","LU0234570918.USD","LU0823416689.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","SG9999001176.USD","LU2362541513.USD","LU0289739699.SGD","LU2362541273.HKD","BK4532","BK4139","BK4567","VRTX","LU1674673691.USD","LU2237438978.USD","BK4585","LU1430594728.SGD","LU2324357040.USD","LU2456880835.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0417517546.SGD","IE00B894F039.SGD","SGXZ57979304.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","LU2362540622.SGD","LU1778281490.HKD","LU2236285917.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU2417539215.USD","LU0061475181.USD","LU0079474960.USD","LU2462157665.USD","IE0002141913.USD","BK4588","LU0058720904.USD"],"gpt_icon":0},{"id":"2558200575","title":"Vertex, Inc.盘中异动 早盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558200575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558200575?lang=zh_cn&edition=full","pubTime":"2025-08-08 23:21","pubTimestamp":1754666516,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日23时21分，Vertex, Inc.股票出现异动，股价急速下挫5.02%。Vertex, Inc.股票所在的软件服务行业中，整体跌幅为0.23%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808232156a47d852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362540622.SGD","BK4588","IE00B19Z9P08.USD","LU2417539215.USD","IE00BJJMRZ35.SGD","LU2462157665.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","LU1585245621.USD","VERX","IE00BJT1NW94.SGD","LU0889565916.HKD","LU1778281490.HKD","LU2324357040.USD","LU2362541513.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0823416689.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU0757428866.USD","LU1674673428.USD","LU0061475181.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","LU0417517546.SGD","BK4567","LU0289739699.SGD","LU2456880835.USD","LU2236285917.USD","LU1430594728.SGD","IE00B894F039.SGD","LU1815336091.USD","LU2362541273.HKD","BK4533","IE00BZ9MQY76.HKD","LU0079474960.USD","LU0234570918.USD","LU2237438978.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU1069344957.HKD","SGXZ57979304.SGD","BK4532","IE0002141913.USD","IE0002270589.USD","VRTX","LU0058720904.USD","LU0256863811.USD"],"gpt_icon":0},{"id":"2557547023","title":"福泰制药8月7日成交额为15.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557547023","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557547023?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:06","pubTimestamp":1754640400,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，福泰制药成交额为15.13亿美元，成交额较昨日减少16.69%，当日成交量为399.55万股。福泰制药于2025年8月7日跌2.6%，报375.63美元，该股过去5个交易日跌17.78%，年初至今跌6.72%，过去60日跌14.51%。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。福泰也在研究细胞疗法，为1型糖尿病提供潜在的功能性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808171817a47cec55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4533","BK4532","IE00B19Z9P08.USD","LU0061475181.USD","LU2362541513.USD","SG9999001176.SGD","SG9999013999.USD","LU2237438978.USD","LU0109394709.USD","IE00B894F039.SGD","LU2417539215.USD","SG9999001176.USD","LU2236285917.USD","BK4588","LU0079474960.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","BK4567","LU2462157665.USD","VRTX","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU2362541273.HKD","LU0058720904.USD","SGXZ57979304.SGD","LU1674673428.USD","BK4139","LU0417517546.SGD","LU1093756168.USD","IE0009355771.USD","LU1778281490.HKD","LU0889565916.HKD","LU1674673691.USD","LU1430594728.SGD","LU0823416689.USD","LU0289739699.SGD","LU0234570918.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00B19Z3581.USD","LU2324357040.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","LU1035775433.USD","IE0002270589.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2557561604","title":"Vertex, Inc.盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557561604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557561604?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:52","pubTimestamp":1754574740,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时52分，Vertex, Inc.股票出现波动，股价快速上涨5.50%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.28%。其相关个股中，多邻国、Backblaze, Inc.、Pagaya Technologies Ltd.涨幅较大，Auddia Inc.、Atlasclear Holdings, Inc.、Cemtrex Inc.较为活跃，换手率分别为19.72%、12.87%、5.07%，振幅较大的相关个股有Backblaze, Inc.、Pagaya Technologies Ltd.、Airship Ai Holdings Inc C/Wts 21/12/2028，振幅分别为17.57%、17.47%、16.40%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807215220a47b2d37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4023","IE00B894F039.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU1585245621.USD","SG9999013999.USD","LU0566484027.USD","LU1778281490.HKD","BK4139","LU0234570918.USD","LU2362541273.HKD","LU2462157665.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU2362540622.SGD","SGXZ57979304.SGD","IE00BZ9MQY76.HKD","LU0079474960.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0256863811.USD","LU2417539215.USD","IE00B19Z9P08.USD","LU1674673691.USD","SG9999001176.USD","LU1430594728.SGD","LU1035775433.USD","BK4567","BK4533","LU1559883803.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU1674673428.USD","LU0757428866.USD","LU0320765992.SGD","LU2456880835.USD","VRTX","LU2237438978.USD","BK4585","LU1815336091.USD","IE00B19Z3581.USD","LU0058720904.USD","VERX","BK4532","IE0009355771.USD","LU2324357040.USD","BK4588"],"gpt_icon":0},{"id":"2557011530","title":"福泰制药8月6日成交额为18.16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557011530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557011530?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:00","pubTimestamp":1754553622,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，福泰制药成交额为18.16亿美元，成交额较昨日减少56.57%，当日成交量为472.66万股。福泰制药于2025年8月6日涨2.85%，报385.65美元，该股过去5个交易日跌17.8%，年初至今跌4.23%，过去60日跌9.26%。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。福泰也在研究细胞疗法，为1型糖尿病提供潜在的功能性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807164321a6d85c6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2456880835.USD","LU2462157665.USD","LU0079474960.USD","LU2417539215.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0234570918.USD","LU1674673691.USD","IE0002270589.USD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","LU0061475181.USD","BK4585","LU0889565916.HKD","BK4567","LU1778281490.HKD","LU2362541513.USD","LU0256863811.USD","LU0417517546.SGD","LU0109394709.USD","BK4533","BK4532","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU1035775433.USD","LU1093756325.SGD","SG9999013999.USD","IE00B894F039.SGD","LU1674673428.USD","SGXZ57979304.SGD","LU0058720904.USD","LU2236285917.USD","IE00B2B36J28.USD","LU0823416689.USD","LU1585245621.USD","LU2362541273.HKD","IE0009355771.USD","BK4139","LU2362540622.SGD","LU2237438978.USD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1093756168.USD","LU2324357040.USD","BK4588","LU1069344957.HKD","VRTX","SG9999001176.SGD"],"gpt_icon":0},{"id":"2557538964","title":"美股财报 | Vertex发布Q2财报 前半年累计净利润同比增长29.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557538964","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557538964?lang=zh_cn&edition=full","pubTime":"2025-08-07 12:00","pubTimestamp":1754539215,"startTime":"0","endTime":"0","summary":"Vertex发布Q2财报，2025财年前六月累计收入3.62亿美元，去年同期累计收入为3.18亿美元，同比增长13.76%。Vertex, Inc.是特拉华州的一家公司。该公司是全球领先的间接税软件和解决方案供应商。该公司的使命是提供最值得信赖的税务技术，使全球企业能够交易、合规并充满信心地发展。该公司提供基于云的内部部署解决方案，可以针对每一个主要的间接税领域，包括销售和消费者使用、增值和工资，为特定行业量身定制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120541a47a06ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2557017443","title":"Vertex Pharmaceuticals Shares Rise After Upgrade From Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2557017443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557017443?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:58","pubTimestamp":1754506737,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals shares were up 2.5% in recent Wednesday trading after Wells Fargo upgraded the biotechnology company's stock to overweight from equalweight, with a $460 price target.Trading volume was over 3.64 million shares against a daily average of more than 1.57 million shares.Price: 384.15, Change: +9.17, Percent Change: +2.45","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"富国银行上调评级后，Vertex Pharmaceuticals股价上涨","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2557308685","title":"Vertex, Inc.盘中异动 急速下挫18.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308685?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487138,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，Vertex, Inc.股票出现异动，股价大幅下跌18.39%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.47%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213218a478d866&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1069344957.HKD","LU2362541513.USD","LU0058720904.USD","LU0417517546.SGD","LU1778281490.HKD","LU2362541273.HKD","LU0757428866.USD","BK4533","BK4023","IE00B19Z9P08.USD","LU0289739699.SGD","LU0823416689.USD","LU2362540622.SGD","LU0061475181.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","IE0002141913.USD","SG9999001176.SGD","VRTX","LU1559883803.SGD","LU1035775433.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU0320765992.SGD","LU1093756325.SGD","LU2236285917.USD","IE00B19Z9Z06.USD","BK4585","IE00BZ9MQY76.HKD","LU0234570918.USD","LU2237438978.USD","LU1585245621.USD","IE00B2B36J28.USD","LU1815336091.USD","LU2462157665.USD","IE0002270589.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","SG9999001176.USD","BK4588","BK4532","IE00BFTCPJ56.SGD","BK4567","LU1674673428.USD","VERX","LU2324357040.USD","LU1674673691.USD","BK4139"],"gpt_icon":0},{"id":"2557372887","title":"打不过安慰剂，福泰制药一款镇痛药折戟","url":"https://stock-news.laohu8.com/highlight/detail?id=2557372887","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557372887?lang=zh_cn&edition=full","pubTime":"2025-08-06 20:28","pubTimestamp":1754483280,"startTime":"0","endTime":"0","summary":"福泰制药的镇痛药VX-993在II期临床试验中未能显著优于安慰剂，公司将终止其开发。Nav1.8抑制剂类镇痛药市场潜力巨大，但研发挑战重重。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080620361394d36735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","IE00B2B36J28.USD","IE00B19Z3B42.SGD","LU2456880835.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","IE00BZ9MQY76.HKD","LU2236285917.USD","IE00B19Z3581.USD","LU0061475181.USD","BK4588","LU0889565916.HKD","LU1069344957.HKD","LU0256863811.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2417539215.USD","LU1430594728.SGD","LU2362541273.HKD","LU0058720904.USD","IE00B19Z9Z06.USD","LU0823416689.USD","LU1585245621.USD","LU2362541513.USD","SG9999001176.SGD","LU0079474960.USD","BK4585","BK4567","LU1035775433.USD","SGXZ57979304.SGD","VRTX","SG9999001176.USD","LU0234570918.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002270589.USD","LU0417517546.SGD","LU1674673691.USD","BK4139","LU0109394709.USD","LU2462157665.USD","BK4532","BK4533","LU2324357040.USD","LU1778281490.HKD","IE0002141913.USD","IE00B894F039.SGD"],"gpt_icon":0},{"id":"2557713375","title":"Vertex Q2 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $184.559M Miss $184.595M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557713375","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557713375?lang=zh_cn&edition=full","pubTime":"2025-08-06 19:06","pubTimestamp":1754478405,"startTime":"0","endTime":"0","summary":"Vertex (NASDAQ:VERX) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 5.63 percent. This is unchanged from the same period last year. The company reported quarterly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"顶点第二季度调整后每股收益0.15美元，超出预期0.14美元，销售额1.84559亿美元，低于预期1.84595亿美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46891859/vertex-q2-adj-eps-0-15-beats-0-14-estimate-sales-184-559m-miss-184-595m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERX","VTNR","VRTX"],"gpt_icon":0},{"id":"2557299243","title":"福泰制药8月5日成交额为41.82亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557299243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557299243?lang=zh_cn&edition=full","pubTime":"2025-08-06 15:51","pubTimestamp":1754466667,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，福泰制药成交额为41.82亿美元，成交额较昨日增加282.70%，当日成交量为1072.94万股。福泰制药于2025年8月5日跌20.6%，报374.98美元，该股过去5个交易日跌19.95%，年初至今跌6.88%，过去60日跌12.71%。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806161903a47842d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009355771.USD","LU2417539215.USD","LU2462157665.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1430594728.SGD","BK4139","LU1093756168.USD","LU1035775433.USD","BK4567","BK4585","LU2236285917.USD","LU0234570918.USD","LU0320765992.SGD","BK4588","LU0109394709.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE00B894F039.SGD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","VRTX","SG9999001176.USD","LU0889565916.HKD","LU1674673428.USD","LU2456880835.USD","SGXZ57979304.SGD","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0061475181.USD","IE00BJT1NW94.SGD","SG9999013999.USD","IE00B19Z9P08.USD","LU0823416689.USD","LU1093756325.SGD","LU1585245621.USD","LU2237438978.USD","IE0002270589.USD","IE00B2B36J28.USD","LU2362541513.USD","LU0079474960.USD","BK4532","LU0256863811.USD","LU2362540622.SGD","LU2362541273.HKD","LU1674673691.USD","IE00B19Z9Z06.USD","LU0417517546.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"1177490886","title":"美股成交额TOP 20｜Palantir涨近8%，Coinbase跌超6%；福泰制药绩后跌20%，HIMS跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177490886","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177490886?lang=zh_cn&edition=full","pubTime":"2025-08-06 07:05","pubTimestamp":1754435142,"startTime":"0","endTime":"0","summary":"同时，Palantir上调了全年业绩指引，称其将到达41.42亿美元至41.50亿美元区间，此前预期为38.9亿美元至39亿美元。股东指控他们存在证券欺诈行为，隐瞒了包括Robotaxi在内的公司自动驾驶车辆存在危险这一重大风险。因营收不及预期、加密市场波动性减弱，$Coinbase$股价上周累计下跌19.65%。","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7f3c334ac27b62e5765e61d81b2afdc1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-06/doc-infiyrue8765228.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1687560890796","symbols":["BK4585","HIMS","LU1861558580.USD","LU1093756325.SGD","SG9999001176.USD","IE00B19Z9P08.USD","BK4613","LU0289739699.SGD","PLTR","LU2417539215.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU0058720904.USD","LU1861217088.USD","COIN","VRTX","LU1861220207.SGD","LU1069344957.HKD","LU0109394709.USD","LU0823416689.USD"],"gpt_icon":1},{"id":"2557314722","title":"Palantir营收首破10亿美元，特斯拉遭股东起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2557314722","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557314722?lang=zh_cn&edition=full","pubTime":"2025-08-06 04:58","pubTimestamp":1754427482,"startTime":"0","endTime":"0","summary":"8月5日，美股成交额前20中，Palantir收高7.85%，二季度营收首超10亿美元，同比增长48%，并上调全年业绩指引。该公司受益于AI需求激增及与美军合作，股价年内翻倍。与此同时，特斯拉收跌0.17%，遭股东起诉指控证券欺诈，指其隐瞒自动驾驶技术风险。此外，Hims & Hers营收未达预期引发股价大跌，Coinbase计划发行可转债筹资20亿美元，福泰制药因药物试验失败股价重挫。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"1f2ab9f06b5982a97b23ea78b99fa383","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806045913973604bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRTX","PLTR","TSLA","TSLL"],"gpt_icon":0},{"id":"2557319159","title":"标普500指数初步收跌0.4%科技、电信板块至多跌0.9%。纳斯达克100指数跌0.6%成分股VRTX跌20%格芯跌9.","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557319159?lang=zh_cn&edition=full","pubTime":"2025-08-06 04:00","pubTimestamp":1754424014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1069344957.HKD","LU2456880835.USD","SPXU","LU0321505439.SGD","UPRO","LU0320765992.SGD","ESmain","LU2362541273.HKD","IE0002270589.USD","BK4600",".SPX","BK4023","SG9999013999.USD","LU2324357040.USD","OEF","BK4595","IE0002141913.USD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU0079474960.USD","LU2236285917.USD","LU2462157665.USD","IE00B19Z3581.USD","SDS","SSO","BK4533","LU2148611432.USD","LU0289739699.SGD","MSTU","SPY","LU0256863811.USD","LU2237438978.USD","NDX","BK4512","LU0109394709.USD","SOX","MESmain","OEX","SH","INTC","IVV","LU0823416689.USD","IE0009355771.USD","VRTX","PLTR","STRK","LU1093756168.USD","MSTR","IE00BJJMRZ35.SGD","BK4504"],"gpt_icon":0},{"id":"2557231576","title":"These Analysts Cut Their Forecasts On Vertex Pharmaceuticals After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557231576","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557231576?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:58","pubTimestamp":1754416698,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"这些分析师在第二季度业绩公布后下调了对Vertex Pharmaceuticals的预测","themeId":"cf236ffb5b1f701a443d820042ce3a06","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/46867232/these-analysts-cut-their-forecasts-on-vertex-pharmaceuticals-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU0795875086.SGD","IE00BJJMRZ35.SGD","BK4533","IE00B19Z9P08.USD","LU1093756168.USD","VERX","IE00B19Z9Z06.USD","LU0757428866.USD","IE00BFTCPJ56.SGD","BK4127","LU0823416689.USD","LU0889565916.HKD","LU0795875169.SGD","LU1559883803.SGD","LU1674673691.USD","LU1732799900.SGD","LU1815336091.USD","LU2362540622.SGD","LU2089284900.SGD","SGXZ57979304.SGD","LU2362541273.HKD","LU1035775433.USD","IE00B4R5TH58.HKD","BK4504","LU2237438978.USD","LU2462157665.USD","BK4567","IE00B894F039.SGD","LU0006306889.USD","LU0106261372.USD","LU1668664300.SGD","BK4581","LU1674673428.USD","LU2456880835.USD","LU1585245621.USD","SG9999001176.SGD","BK4516","LU2324357040.USD","VRTX","SG9999013999.USD","BK4532","LU0417517546.SGD","LU1162221912.USD","IE00BJT1NW94.SGD","LU1989772923.USD","LU2417539215.USD"],"gpt_icon":0},{"id":"1147873868","title":"异动解读 | 福泰制药股价盘中大跌15.32%，止痛药VX-993临床试验失败","url":"https://stock-news.laohu8.com/highlight/detail?id=1147873868","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147873868?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:52","pubTimestamp":1754401950,"startTime":"0","endTime":"0","summary":"福泰制药今日盘中股价大跌15.32%，引发市场广泛关注。此次大跌主要源于公司一则重磅消息。据悉，福泰制药备受关注的实验性非阿片类止痛药VX-993在中期临床试验中未能达到主要目标。基于这一结果，福泰制药宣布将不再继续将VX-993作为单独治疗方案进行开发。这一消息对福泰制药在疼痛管理领域的扩张计划造成了重大打击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VRTX"],"gpt_icon":0},{"id":"1166198374","title":"异动解读 | 福泰制药新型止痛药临床试验失败，盘前股价大跌14.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166198374","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166198374?lang=zh_cn&edition=full","pubTime":"2025-08-05 18:06","pubTimestamp":1754388390,"startTime":"0","endTime":"0","summary":"福泰制药周二盘前股价大跌14.64%，主要原因是公司宣布其备受关注的实验性非阿片类止痛药VX-993在中期临床试验中未能达到主要目标。基于这一结果，福泰制药宣布将不再继续将VX-993作为单独治疗方案进行开发。尽管新药研发遭遇挫折，福泰制药在财务表现方面仍然保持稳健。市场将密切关注福泰制药未来在疼痛管理领域的战略调整和其他管线产品的进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VRTX"],"gpt_icon":0},{"id":"2557362593","title":"Bernstein Adjusts PT on Vertex Pharmaceuticals to $471 From $462, Maintains Market Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2557362593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557362593?lang=zh_cn&edition=full","pubTime":"2025-08-05 17:42","pubTimestamp":1754386979,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has an average rating of overweight and mean price target of $499.32, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"伯恩斯坦将Vertex Pharmaceuticals的PT从462美元调整至471美元，维持市场表现评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PT","VRTX","VERX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":0.0391},{"period":"1month","weight":-0.1592},{"period":"3month","weight":-0.1102},{"period":"6month","weight":-0.1497},{"period":"1year","weight":-0.1721},{"period":"ytd","weight":-0.0308}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0367},{"period":"3month","weight":0.0854},{"period":"6month","weight":0.0578},{"period":"1year","weight":0.1861},{"period":"ytd","weight":0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品：KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.647059,"avgChangeRate":0.034332},{"month":2,"riseRate":0.441176,"avgChangeRate":-0.000038},{"month":3,"riseRate":0.441176,"avgChangeRate":-0.019628},{"month":4,"riseRate":0.617647,"avgChangeRate":0.018103},{"month":5,"riseRate":0.558824,"avgChangeRate":0.077818},{"month":6,"riseRate":0.558824,"avgChangeRate":0.028419},{"month":7,"riseRate":0.470588,"avgChangeRate":-0.004622},{"month":8,"riseRate":0.628571,"avgChangeRate":0.04628},{"month":9,"riseRate":0.470588,"avgChangeRate":0.031033},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.001666},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.021411},{"month":12,"riseRate":0.647059,"avgChangeRate":0.072354}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}